AN EMPIRICAL REVIEW OF THE IMPACT OF TRIPLICATE PRESCRIPTION OF BENZODIAZEPINES

In 1989 New York became the first state to add benzodiazepines to the list of controlled substances requiring a triplicate prescription, all owing the state to track prescribing patterns and target providers, ph armacies, and patients for investigation when misuse is suspected. Stu dies by the state reporting that regulation has significantly reduced inappropriate prescribing and illicit diversion of benzodiazepines wit hout affecting legitimate prescribing practices are being challenged b y other studies showing that patients with legitimate needs for benzod iazepines are being denied them, often after abrupt discontinuation. S everal reports indicate a significant increase in the prescribing of b enzodiazepine substitutes that are less safe and effective, along with increased overdoses of some substitute drugs. Changes in physicians' legitimate prescribing practices may reflect their fears of the damage to career and peace of mind that follows investigations by regulatory agencies.